Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsPayablesPrepaid AssetsReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cyclerion Therapeutics (CYCN) Total Current Liabilities (2019 - 2025)

Cyclerion Therapeutics has reported Total Current Liabilities over the past 7 years, most recently at $877000.0 for Q3 2025.

  • Quarterly results put Total Current Liabilities at $877000.0 for Q3 2025, up 25.29% from a year ago — trailing twelve months through Sep 2025 was $877000.0 (up 25.29% YoY), and the annual figure for FY2024 was $725000.0, down 65.24%.
  • Total Current Liabilities for Q3 2025 was $877000.0 at Cyclerion Therapeutics, up from $800000.0 in the prior quarter.
  • Over the last five years, Total Current Liabilities for CYCN hit a ceiling of $13.5 million in Q1 2021 and a floor of $700000.0 in Q3 2024.
  • Median Total Current Liabilities over the past 5 years was $4.9 million (2023), compared with a mean of $5.6 million.
  • Biggest five-year swings in Total Current Liabilities: tumbled 80.87% in 2024 and later rose 25.29% in 2025.
  • Cyclerion Therapeutics' Total Current Liabilities stood at $11.1 million in 2021, then crashed by 31.2% to $7.6 million in 2022, then plummeted by 72.65% to $2.1 million in 2023, then crashed by 65.24% to $725000.0 in 2024, then rose by 20.97% to $877000.0 in 2025.
  • The last three reported values for Total Current Liabilities were $877000.0 (Q3 2025), $800000.0 (Q2 2025), and $1.1 million (Q1 2025) per Business Quant data.